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Abstract 
Background: Due to this belief that opium may have beneficial effects on diabetes or cardiovascular risk 
factors, the present study aimed to assess the potential and possible effects of opium consumption on 
diabetes control and some cardiovascular risk factors in diabetic patients. 
Methods: This study enrolled 374 diabetic subjects from diabetes care centers in Kerman, Iran, including 
opium user group (n = 179) and a non-opium user group (n = 195). The data were collected through a 
questionnaire completed by interviewing, physical examination and laboratory assessment. 
Findings: Opium did not show any statistically significant effect on blood glucose, glycated hemoglobin 
(HbA1C), fasting blood sugar (FBS), low-density lipoprotein (LDL) and diastolic blood pressure. However, 
systolic blood pressure (SBP) and prevalence of high SBP were significantly higher in opium user group  
(P < 0.050). In addition, lower serum high-density lipoprotein (HDL) and frequency of lower HDL was 
significantly higher in opium user group (P < 0.001). 
Conclusion: According to this study, opium does not seem to have beneficial effects on diabetes control or 
cardiovascular risk factors. Therefore, it would not be advisable to consume opium as an anti-diabetes or 
cardioprotective agent. 
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Introduction 
Opium dependence is one of the health problems 
in the Middle East countries including Iran and 
Afghanistan. In some parts of Iran, the prevalence 
of dependency is very high. Based on the study of 
Ziaaddini and Ziaaddini, the prevalence in 
general population is 5.3% reaching to 22.5% in 
some rural areas.1 In Fars province, the prevalence 
was reported in general population to be 8.8%.2 
To some extent, the problem comes from the lay 
belief of many people i.e. opium has therapeutic 
effects on some metabolic diseases and also 
related antinociceptive effects as well. Based on 
some old medicine sources, opium may be an 
alternative for treatment of chronic diseases such 
as diabetes, cardiac diseases and hypertension. 
Sa’di Shirazi, the famous Iranian poets in The 
Golestan says: "Poison will kill where there is no 
opium". Therefore, the prevalence is rising in 
patients with chronic diseases,3-5 mostly those 
with less knowledge about the side effects of 
opium consumption. 
Regarding the effect of opium on diabetes and 
cardiovascular disease (CVD), there is 
controversies from the reduction in blood glucose 
and CVD risk factors,6,7 no effect on these factors8,9 
to normal glucose tolerance test in opium 
users.10,11 In contrast. some studies have come to 
this conclusion that opium facilitates incidence of 
CVD risk factors.12,13 In some cases, reduction in 
response to insulin against glucose has been 
reported in opium users.14-16 Another study has 
reported increase in hyperglycemia due to 
discontinuing of opium consumption.17 Therefore, 
due to poor knowledge on the effect of opium 
especially in diabetes control, the present study 
aimed to investigate the effects of opium in 
diabetes control and on CVD risk factors. The 
information provided may help to increase the 
knowledge of general population about opium 
effects and probably to be effective in prevention 
dependency. Furthermore, presenting new 
functional guides and programs in control of 
diabetes in diabetic patients consuming opium 
will be approachable. 
Methods 
This controlled cross-sectional study was 
performed on patients referred to Kerman, Iran, 
diabetes centers after obtaining informed consent. 
Participants were 374 subjects including 179 
opium addicts and 195 control (non-addicts) 
subjects. The study was confirmed by the Ethics 
Committee of Kerman University of Medical 
Sciences (permission No. 88/110KA). The patients 
were assured that the information were 
confidential and used only for research purposes 
and asked them to disclose any drug 
consumption. The consumers were subjects who 
were using opium regularly at least in last three 
months and the withdrawal signs would appear 
in them if discontinued opium consumption. 
The data were recorded in a questionnaire of 
demographic characteristics, physical 
examination and some laboratory tests consisted 
of serum lipid profile, indices of diabetes control 
[fasting blood sugar (FBS) and glycated 
hemoglobin (HbA1C)]. The exclusive criteria were 
type I diabetes, history of thyroid or renal 
diseases and taking other alkaloid drugs except 
opium. The data were analyzed using SPSS for 
Windows (SPSS Inc., Chicago, IL, USA). 
Independent t-test, logistic regression and  
chi-square tests were used for comparison of data 
between the case and control groups accordingly. 
P value less than 0.05 was considered as a 
statistically significant level. 
Results 
The number of subjects in addicted and 
non-addicted groups were 179 (47.9%) and 195 
(52.1%), respectively. The descriptive 
characteristics and baseline clinical features of the 
addicted and non-addicted subjects are presented 
in table 1. The frequency of male gender and 
current cigarette smoking were significantly more 
in the opium user group (P < 0.001). Mean age in 
addicted group (58.2 ± 9.5) was significantly 
higher than the non-addicted ones (53.5 ± 9.7) 
(P < 0.001). Body mass index (BMI) in the  
non-addicted group was higher (P = 0.009), i.e. the 
frequency of overweight and obesity in  
non-addicted group was more than the addicted 
group. Likewise, mean systolic blood pressure 
(SBP) was significantly different between the two 
groups (P < 0.050). High-density lipoprotein 
(HDL) in the addicted group was significantly 
lower than the non-addicted group (P < 0.001), i.e. 
the frequency of abnormal HDL in the addicted 
and non-addicted was 69.0% and 44.0%, 
respectively. There was no statistically significant 
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difference between the opium and non-opium 
users in terms of other clinical variables including 
mean and frequency of high diastolic blood 
pressure, HbA1c, FBS, cholesterol, triglyceride 
(TG) and low-density lipoprotein (LDL) (Table 1). 
Table 2 shows the effect of opium on 
biochemical factors analyzed by univariate and 
multivariate logistic regression tests. In bivariate 
analysis, except for the low HDL, the effect of 
opium on other variables was not statistically 
significant including systolic and diastolic blood 
pressure, abnormal cholesterol, LDL, TG, FBS and 
HbA1c. However, the effect of opium on HDL 
was still significant with odds ratio of 2.83  
(P < 0.001). When the association was adjusted for 
the age, sex, BMI, cigarette smoking, and HbA1C, 
no statistically significant difference was observed 
between the two groups except for the HDL that 
its odds ratio reached to 3.47 (95% CI: 1.89-6.30;  
P < 0.001). 
 
Table 1. Comparison of the baseline characteristics between the opium user and non-user groups 
Variables Addicted group Non-addicted group P 
Sex (% male) 101 (56.4) 31 (15.9) < 0.001 
Mean age (year) 58.2 ± 9.5 53.5 ± 9.7 < 0.001 
Mean BMI (Kg.m-1) 26.3 ± 5.6 27.7 ± 4.4 0.009 
BMI categories (%) 
Normal  70 (41.2) 47 (27.3) 
0.025 Overweight  60 (35.3) 72 (41.9) 
Obese  40 (23.5) 53 (30.8) 
Current cigarette smoking (%) 39 (21.8) 6 (3.1) < 0.001 
HbA1c 8.5 ± 1.8 8.5 ± 2.1 0.970 
Mean systolic BP 131.2 ± 20.1 125.7 ± 26.4 0.027 
Systolic BP (%) 98 (55.4) 95 (50.3) 0.320 
Mean diastolic BP 79.9 ± 11.3 79.3 ± 10.9 0.620 
Diastolic BP (%) 118 (66.7) 131 (69.3) 0.580 
Hypertension 132 (74.6) 141 (74.6) 0.990 
Mean FBS 172.1 ± 73.1 177.6 ± 66.1 0.440 
Abnormal FBS (%) 118 (67.0) 143 (74.1) 0.137 
Mean cholesterol  194.1 ± 49.6 196.9 ± 40.6 0.550 
Abnormal cholesterol (%) 73 (42.2) 86 (48.3) 0.250 
Mean triglyceride 201.5 ± 157.3 200.1 ± 99.8 0.910 
Abnormal triglyceride (%) 101 (58.4) 121 (67.6) 0.073 
Mean HDL 38.6 ± 10.9 49.8 ± 12.2 < 0.001 
Abnormal HDL (%) 119 (69.6) 75 (44.6) < 0.001 
Mean LDL 117.6 ± 40.7 109.4 ± 34.2 0.052 
Abnormal LDL (%) 102 (64.2) 93 (58.1) 0.270 
BMI: Body mass index; BP: Blood pressure; FBS: Fasting blood sugar; HDL: High-density lipoprotein;  
LDL: Low-density lipoprotein 
 
Table 2. Multivariate logistic regression analysis of different factors affected by opium 
Variables Crude analysis Adjusted analysis
*
 
Odds ratio CI 95% P Odds ratio CI 95% P 
SBP 1.22 0.81-1.85 0.320 1.09 0.63-1.80 0.750 
DBP  0.88 0.57-1.37 0.580 1.12 0.62-2.01 0.700 
Low HDL  2.83 1.80-4.40 < 0.001 3.47 1.89-6.30 < 0.001 
Abnormal LDL 1.28 0.82-2.10 0.270 1.40 0.78-2.50 0.250 
Abnormal Cholesterol  0.78 0.51-1.20 0.250 0.86 0.49-1.50 0.610 
Abnormal TG 0.67 0.43-1.04 0.074 0.84 0.47-1.50 0.560 
Abnormal FBS 0.71 0.45-1.11 0.130 1.58 0.80-3.10 0.180 
HbA1c  0.87 0.52-1.45 0.600 1.28 0.69-2.30 0.420 
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TG: Triglyceride; HDL: High-density lipoprotein;  
LDL: Low-density lipoprotein; FBS: Fasting blood sugar 
*Adjusted for age, sex, BMI, cigarette smoking, and HbA1c 
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Discussion 
This study assessed the effect of opium on diabetes 
control and some cardiovascular risk factors in 
diabetic patients. High SBP and prevalence of high 
SBP (P < 0.050) and also lower serum HDL and 
frequency of lower HDL were significantly higher 
in opium user group (P < 0.001). Since HDL is a 
protective factor against coronary artery disease, 
this reduction may cause deleterious 
cardiovascular effects. Angiographic studies on 
addicted patients have shown severe stenosis in 
epicardial coronary vessels and presence of 
atherosclerotic plaques in carotid arteries.7,18 
Moreover, in animal studies a trend of athroma 
plaque formation in carotid artery of  
opium-addicted hypercholesterolemic rabbits has 
been reported.14 
Regarding the effects of opium on CVD risk 
factors, Fatemi et al. reported reduction in total 
cholesterol.6 In contrast, some studies have 
rejected the effect of opium on lipid profile.7-9 
Some studies have reported the effect of opium 
on serum lipoproteins. Asgary et al. observed 
reduction in lipoprotein a, Apo-b, fibrinogen, 
factor 7 and C-reactive protein (CRP).11 Karam  
et al.13 and Mohammadi et al. reported similar 
results.14 There are few factors that affect the 
cholesterol level such as food regimen, 
malnutrition and physical activity that may be 
different between addicted and non-addicted 
subjects, as BMI was significantly less in opium 
users in the present study. These results were 
verified in the study of Fatemi et al.6 The 
probable reason may be the impact of medicines, 
different food regimens and some other 
difficulties in addicted subjects. Psycho-social 
problems, reduced appetite, food restrictions 
after opium consumption, periods of drowsiness 
and low economy may have had negative effects 
on calorie intake and leading to weight reduction 
in these subjects.  
In association with diabetes control, blood 
sugar (BS) and HbA1C were similar in the two 
groups. There are different reports about the 
effect of opium on blood glucose. Sadeghian et al. 
in their study on diabetic rats found no difference 
in BS.8 In contrast, in a cross-sectional study Azod 
et al. observed a significant reduction in FBS and 
BS of addicts, though HbA1C was similar in the 
two groups.9 Shirani et al. has also reported a 
lower level of HbA1C in opium addicts.7 
However, Asgary et al.11 and Karam et al.13 found 
a higher level of HbA1C in addicted subjects. The 
discrepancy in results might be due to differences 
in sampling or human vs. animal studies. 
Regarding the of opium effects, various 
mechanisms have proposed such as increased 
adrenaline, adrenocorticotropic hormone (ACTH) 
and cortisol19 and glucagon20 that are known as 
glucose counter regulatory hormones. Based on 
these results, it seems more studies are needed to 
clarify the fact. 
The results of this study for the effect on blood 
pressure showed that there was a statistically 
significant increase in systolic BP in opium user 
compared to the control group, but in 
multivariate analysis logistic regression, abnormal 
SBP was not different (P = 0.320). In some 
previous studies, difference in prevalence of 
hypertension have been reported between the 
opium user and non-users.7,18 Even passive opium 
smokings have shown to increase blood pressure 
of hypercholestrolemic rabbits.21 Some studies 
have mentioned the changes in hormone levels by 
opium as the reason for these effects.19,20  
Nevertheless, more investigations are still 
needed for clarification of the direct effect of 
opium on weight, lipid profile, blood glucose and 
blood pressure. A number of potential limitations 
of the current investigation have to be considered. 
First, this study was a cross-sectional study; the 
correlation of the variable should be interpreted 
with caution. Second, it should be considered that 
the existing opium in the community was 
handmade; consequently it has not identical 
chemical compounds. A final potential limitation 
was that self-reporting was not reliable due to the 
concealment of some of opium user; therefore, it 
would be better to utilize specific laboratory tests 
for confirmation of their reporting. 
Conclusion 
According to this study, opium consumption may 
have deleterious effect on HDL-c but did not have 
considerable effects on other lipid profile  
(TG, cholesterol, LDL-c), blood glucose and blood 
pressure. Despite lower BMI in opium users, there 
was higher frequency of disturbances in blood 
pressure and HDL-c in this group. Therefore, 
based on the results of this study the belief of 
some people was not approved about the 
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protective effect of opium on control of diabetes 
and other CVD risk factors. 
Conflict of Interests 
The Authors have no conflict of interest.  
Acknowledgements 
It would be the authors’ pleasure to express their 
gratitude to Dr. Haghdoost, the epidemiologist; and 
also diabetes treatment centers in Kerman, Iran. 
 
References 
1. Ziaaddini H, Ziaadini MR. The household survey of 
drug abuse in Kerman, Iran. J Applied Sci 2005; 
5(2): 380-2. 
2. Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad 
A, Parsaeyan H, et al. Epidemiology of opium use 
in the general population. Am J Drug Alcohol 
Abuse 2007; 33(3): 483-91. 
3. Zargham M, Khalilian AR, Tajic Jalayeri H, 
Khadivi Sohrabi S, editors. Study of frequency, 
situation and beliefs on opium consumtion in the 
elderly. Proceedings of the National Congress on 
Addiction; Challenges, Treatments; 2002 Oct 
30- Nov 1; Zanjan, Iran. [In Persian]. 
4. Ghazvininejad H, editor. Incorrect beliefs on drugs. 
Proceedings of the National Congress on Addiction; 
Challenges, Treatments; 2002 Oct 30- Nov 1; 
Zanjan, Iran. [In Persian]. 
5. Sadr SS, Mahmoudinia SA, Bakhtiari M. Frequency 
of opium use among diabetic patients and their 
attitude. Iran J Psychiatry Behav Sci 2009; 3(2): 33-8. 
6. Fatemi SS, Hasanzadeh M, Arghami A, Sargolzaee 
MR. Lipid Profile Comparison between Opium 
Addicts and Non-Addicts. J Tehran Univ Heart 
Cent 2008; 3(3): 169-72. 
7. Shirani S, Shakiba M, Soleymanzadeh M, 
Esfandbod M. Can opium abuse be a risk factor for 
carotid stenosis in patients who are candidates for 
coronary artery bypass grafting? Cardiol J 2010; 
17(3): 254-8. 
8. Sadeghian S, Boroumand MA, Sotoudeh-Anvari M, 
Rabbani S, Sheikhfathollahi M, Abbasi A. Effect of 
opium on glucose metabolism and lipid profiles in 
rats with streptozotocin-induced diabetes. 
Endokrynol Pol 2009; 60(4): 258-62. 
9. Azod L, Rashidi M, Afkhami-Ardekani M, Kiani 
G, Khoshkam F. Effect of opium addiction on 
diabetes. Am J Drug Alcohol Abuse 2008; 34(4): 
383-8. 
10. Vescovi PP, Gerra G, Rastelli G, Ceda GP, Valenti G. 
Effect of methadone on TSH and thyroid hormone 
secretion. Horm Metab Res 1984; 16(1): 53-4. 
11. Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani 
R. Effect of opium addiction on new and traditional 
cardiovascular risk factors: do duration of addiction 
and route of administration matter? Lipids Health 
Dis 2008; 7: 42. 
12. Rezvanfar MR, Farahany H, Rafiee M, Kaboli S. 
Opium Consumption Challenge and Diabetes 
Mellitus Control. Iran J diabetes Obes 2011; 3(2): 
72-6. 
13. Karam GA, Reisi M, Kaseb AA, Khaksari M, 
Mohammadi A, Mahmoodi M. Effects of opium 
addiction on some serum factors in addicts with 
non-insulin-dependent diabetes mellitus. Addict 
Biol 2004; 9(1): 53-8. 
14. Mohammadi A, Darabi M, Nasry M, Saabet-
Jahromi MJ, Malek-Pour-Afshar R, Sheibani H. 
Effect of opium addiction on lipid profile and 
atherosclerosis formation in hypercholesterolemic 
rabbits. Exp Toxicol Pathol 2009; 61(2): 145-9. 
15. Passariello N, Giugliano D, Quatraro A, Consoli G, 
Sgambato S, Torella R, et al. Glucose tolerance and 
hormonal responses in heroin addicts. A possible 
role for endogenous opiates in the pathogenesis of 
non-insulin-dependent diabetes. Metabolism 1983; 
32(12): 1163-5. 
16. Giugliano D, Quatraro A, Consoli G, Stante A, 
Simeone V, Ceriello A, et al. Sodium salicylate 
restores the impaired insulin response to glucose 
and improves glucose tolerance in heroin addicts. 
Acta Diabetol Lat 1987; 24(3): 205-12. 
17. Ceriello A, Giugliano D, Passariello N, Quatraro A, 
Dello RP, Torella R, et al. Impaired glucose 
metabolism in heroin and methadone users. Horm 
Metab Res 1987; 19(9): 430-3. 
18. Schultz JE, Gross GJ. Opioids and cardioprotection. 
Pharmacol Ther 2001; 89(2): 123-37. 
19. Bossone CA, Hannon JP. Metabolic actions of 
morphine in conscious chronically instrumented 
pigs. Am J Physiol 1991; 260(6 Pt 2): 
R1051-R1057. 
20. Molina PE, Jabbour K, Williams P, Abumrad NN. 
Effect of acute ethanol intoxication on 
glucoregulation during prolonged insulin-induced 
hypoglycemia. Am J Physiol 1994; 267(5 Pt 2): 
R1280-R1287. 
21. Najafipour H, Joukar S, Malekpour-Afshar R, 
Mirzaeipour F, Nasri HR. Passive opium smoking 
does not have beneficial effect on plasma lipids and 
cardiovascular indices in hypercholesterolemic 
rabbits with ischemic and non-ischemic hearts. J 
Ethnopharmacol 2010; 127(2): 257-63. 
Cardiovascular Risk Factors and Opium Consumption in Diabetic Patients Rahimi et al. 
 
1- 	 
      
  !  !  "#$ 
% 
2-  ' 
  (#)#* +,,-. !    
  !  !  "#$ 
% 
3-  (#)#* 
  (#)#* +,,-. !    
  !  !  "#$ 
% 
4- +,,-. !  1   2 3 4  
5
67 3 4  5
%   !  "#$  !   
5- $ 
% (#)#* +,,-. !    ! 6	 9 
% 2 "#$  	 3	. 
 2 (#)#* 
   !  !  "#  
  :
 *:  ; !  Email: h.marefati@yahoo.com   
 
 
6 Addict Health, Winter & Spring 2014; Vol 6, No 1-2 
 
http://ahj.kmu.ac.ir,    4 April 
 
   	
         !"- $
 "  
%$ 	
 & '  
  
 	 
1   
 2	  
  3   4 "
#  
5  
  
  
%&  
:    	
   	 	          !"#$- & 	'& !$	()  *+ ,   ! 
   !-(   .'
   */      	 0'" 1  .  
 : 	() 34   374   	 0'"  8
   9& 1
)  1;
 */ & ,179 (  */ ? @; 
)  @
195  (& BC.   D0E FE 	"4/, !8G 	(  H I + ; 	9.  
 : !(    ,1 $   LDL )Low-density lipoprotein ,(FBS )Fasting blood sugar ,(HbA1C  1 JG 
)  K ! @
 */ @;  K 1 JG !CG L&  !)'M 1 JG 	
 N+ .C 1JC !)'050/0 < P  (
 Q R+  HDL )High-density lipoprotein !CG  ! (  HDL !( & 	 ! 1;
 */   
)  K001/0 < P(.  
 : !C SC 	 ,	()  T     .'
   D  */    !"#$- 1  !$ 
!C 	U !"#$ VGW   3  X 1 	  */  .& 	'&  	 0'" &.  
:  !"#$    ,T'#  , - 1 JG ,1 !N DK0' ,!$  
: ! <= >?; -  @ A= ; ; *:  <BC  # ; #.  "#$  %$& 
 $ '( )* "+,- .
/0# 12 "34- %$& $ 63 ,$ & "42. 3 4  $ A=  1393 F6 )2-1( :6-1.  
 :(")* +*),28/4/92   :-
* +*),30/7/92  
 
  
()* &+ 
